BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND MTCP1, C6_1B, 4515, ENSG00000214827, GS1-273L24_4 AND Staging
2549 results:

  • 1. Clinical values of different specimen preparation methods for the diagnosis of lung cancer by EBUS-TBNA.
    Wang H; Wang J; Liu Y; Wang Y; Zhou Y; Yu D; You H; Ren T; Tang Y; Wang M
    Diagn Pathol; 2024 Apr; 19(1):61. PubMed ID: 38641621
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Triple-induction treatment for locally advanced non-small cell lung cancer: a case report of pathological complete response.
    Werner RS; Lauk O; Tscherry G; Curioni-Fontecedro A; Höller S; Opitz I
    J Cardiothorac Surg; 2024 Apr; 19(1):207. PubMed ID: 38616248
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Alectinib in Resected
    Wu YL; Dziadziuszko R; Ahn JS; Barlesi F; Nishio M; Lee DH; Lee JS; Zhong W; Horinouchi H; Mao W; Hochmair M; de Marinis F; Migliorino MR; Bondarenko I; Lu S; Wang Q; Ochi Lohmann T; Xu T; Cardona A; Ruf T; Noe J; Solomon BJ;
    N Engl J Med; 2024 Apr; 390(14):1265-1276. PubMed ID: 38598794
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comprehensive assessment of risk factors and pathogenic characteristics of wound infections following thoracoscopic radical resection for lung cancer.
    Xu J; Zhu J
    Int Wound J; 2024 Apr; 21(4):e14830. PubMed ID: 38531534
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The association of visceral pleural invasion with skip N2 metastasis on clinical stage IA NSCLC.
    Minamoto F; Araújo P; D'Ambrosio P; Dela Vega A; Lauricella L; Pêgo-Fernandes P; Terra R
    Clinics (Sao Paulo); 2024; 79():100334. PubMed ID: 38484584
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Validation of the 9th edition of the TNM staging system for non-small cell lung cancer with lobectomy in stage IA-IIIA.
    Wang RR; Li MJ; Peng Q; Huang ZY; Wu LL; Xie D
    Eur J Cardiothorac Surg; 2024 Mar; 65(3):. PubMed ID: 38426334
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Time between imaging and surgery is not a risk factor for upstaging of clinical stage IA non-small-cell lung cancer.
    Barcelos RR; Sugarbaker E; Kennedy KF; McAllister M; Kim S; Herrera-Zamora J; Leo R; Swanson S; Ugalde Figueroa P
    Eur J Cardiothorac Surg; 2024 Feb; 65(2):. PubMed ID: 38407382
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibition.
    Saal J; Bald T; Eckstein M; Ralser DJ; Brossart P; Ellinger J; Hölzel M; Klümper N
    Lung Cancer; 2024 Mar; 189():107505. PubMed ID: 38367405
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Ductal prostate cancer staging: Role of PSMA PET/CT.
    Pepe P; Pepe L; Curduman M; Pennisi M; Fraggetta F
    Arch Ital Urol Androl; 2024 Feb; 96(1):12132. PubMed ID: 38363231
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Value of
    Zhang J; Jin F; Li C; Jiang W; Liu C; Zeng L; Jiang Y; Xu A; Fang N; Wang Y
    Clin Imaging; 2024 Apr; 108():110100. PubMed ID: 38341881
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysis.
    Zhang KD; Jost E; Panse J; Herwartz R; Lindemann-Docter K; Jonigk D; Kricheldorf K; Köchel A; Sauerbrunn N; Brümmendorf TH; Koschmieder S; Isfort S
    Ann Hematol; 2024 Apr; 103(4):1149-1158. PubMed ID: 38336973
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The value of the first postoperative diagnostic I-131 scan in patients with papillary thyroid carcinoma.
    Ran B; Shang J; Chen Y; Zhou M; Li H; He W; Li Y; Cai Q; Guo B; Gong J; Xu H
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):80. PubMed ID: 38319395
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Dual-energy computed tomography for evaluating nodal staging in lung adenocarcinoma: correlation with surgical pathology.
    Huang HC; Huang YS; Chang YC; Shih JY; Chen JS; Chang YC; Wang TC
    Jpn J Radiol; 2024 May; 42(5):468-475. PubMed ID: 38311704
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Survival according to the site of metastasis in triple-negative breast cancer patients: The Peruvian experience.
    Piedra-Delgado L; Chambergo-Michilot D; Morante Z; Fairen C; Jerves-Coello F; Luque-Benavides R; Casas F; Bustamante E; Razuri-Bustamante C; Torres-Roman JS; Fuentes H; Gomez H; Narvaez-Rojas A; De la Cruz-Ku G; Araujo J
    PLoS One; 2024; 19(2):e0293833. PubMed ID: 38300959
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Impact of Pleural Lavage Cytology Positivity on Early Recurrence After Surgery for Non-Small Cell lung cancer.
    Recuero Díaz JL; Gatius Caldero S; Rosado Rodríguez J; Caamaño Villaverde V; Gómez de Antonio D; Tejerina E; Sánchez Moreno L; Martino González M; Moldes Rodríguez M; Abdulkader Nallib I; Ramírez Gil E; Amat Villegas I; Genovés Crespo M; García Ángel R; Sampedro Salinas C; Figueroa Almánzar S; Compañ Quilis A; Saumench Perramon R; González Pont G; Royo Crespo Í; Gambó Grasa P; García Fernández JL; Jiménez Heffernan JA; Cerón Navarro J; Prieto Rodríguez M; Porcel JM
    Arch Bronconeumol; 2024 Mar; 60(3):133-142. PubMed ID: 38238188
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. LncRNA AL139294.1 can be transported by extracellular vesicles to promote the oncogenic behaviour of recipient cells through activation of the Wnt and NF-κB2 pathways in non-small-cell lung cancer.
    Ma X; Chen Z; Chen W; Chen Z; Shang Y; Zhao Y; Li L; Zhou C; He J; Meng X
    J Exp Clin Cancer Res; 2024 Jan; 43(1):20. PubMed ID: 38229152
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Secondary Analysis of the Rate of Second Primary lung cancer From cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell lung cancer.
    Stinchcombe TE; Wang X; Damman B; Mentlick J; Landreneau R; Wigle D; Jones DR; Conti M; Ashrafi AS; Liberman M; de Perrot M; Mitchell JD; Keenan R; Bauer T; Miller D; Altorki N
    J Clin Oncol; 2024 Apr; 42(10):1110-1113. PubMed ID: 38215351
    [No Abstract]    [Full Text] [Related]  

  • 18. Accelerated Hypofractionated Chemoradiation Followed by Stereotactic Ablative Radiotherapy Boost for Locally Advanced, Unresectable Non-Small Cell lung cancer: A Nonrandomized Controlled Trial.
    Wu TC; Luterstein E; Neilsen BK; Goldman JW; Garon EB; Lee JM; Felix C; Cao M; Tenn SE; Low DA; Kupelian PA; Steinberg ML; Lee P
    JAMA Oncol; 2024 Mar; 10(3):352-359. PubMed ID: 38206614
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Sublobar resection is associated with less lymph nodes examined and lower delivery of adjuvant therapy in patients with 1.5- to 2.0-cm clinical IA2 non-small-cell lung cancer: a retrospective cohort study.
    Rodriguez-Quintero JH; Kamel MK; Jindani R; Vimolratana M; Chudgar NP; Stiles BM
    Eur J Cardiothorac Surg; 2024 Jan; 65(1):. PubMed ID: 38147358
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Impact of preoperative [
    Lin JT; Li XM; Zhong WZ; Hou QY; Liu CL; Yu XY; Ye KY; Cheng YL; Du JY; Sun YQ; Zhang FG; Yan HH; Liao RQ; Dong S; Jiang BY; Liu SY; Wu YL; Yang XN
    Ann Nucl Med; 2024 Mar; 38(3):188-198. PubMed ID: 38145431
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 128.